Related research shows blood or urine sample can be used
UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the Annual Meeting of American Association for the Study of Liver Disease (AASLD) in San Francisco, Nov. 14-16. Current blood-based HCV testing requires two steps and can be expensive, inconvenient and is not widely available or affordable globally.
“Our novel HCV antigen test system has significantly improved sensitivity and specificity over current tests. Importantly, for the first time, we can use urine specimens for one-step screening and diagnosing of HCV infection,” said Hu, professor of gastroenterology and hepatology at UC Irvine School of Medicine. “Finding a more convenient, easy-to-use and cost-effective screening alternative is imperative, because HCV is significantly under-screened and under-diagnosed.”
Although the current HCV screening test is specific and sensitive, it cannot distinguish active infection from a previous infection. A blood sample is required, and two steps are required. First, virus-specific antibodies must be detected in the blood. Then, the sensitive HCV RNA PCR test must be administered to confirm whether or not the infection is active. Hu said many developing countries are not equipped to administer the two-step test, especially the HCV RNA PCR test. In the U.S., its cost is above $200. The novel HCV antigen test system developed by Hu’s UC Irvine lab could significantly reduce the cost, human resources and time required for the test results.
“The ability to detect infection using urine rather than blood avoids needle stick and blood sample collection, greatly reduces the cost and necessary clinical infrastructure for screening and diagnosis, helping to promote widespread adoption of the test on a global scale,” Hu said.
According to the Centers for Disease Control and Prevention, approximately 150 million people worldwide and 3.2 million people in the U.S. are infected with HCV. Effective screening and fast diagnosis are critical for treatment and controlling transmission.
“Those who are HCV infected can now be cured, before a further liver injury and complications develop, but only if they are diagnosed” Hu said.
The Latest on: Hepatitis C
via Google News
The Latest on: Hepatitis C
- Hepatitis C Drug Market Expected To Raise at Healthy CAGR by 2019-2024 | AbbVie, Gilead, Kenilworthon October 15, 2019 at 5:43 am
Oct 15, 2019 (Reporthive Research via COMTEX) -- The report comes out as a keen and intensive assessment device just as an extraordinary asset that will assist you with securing a place of solidarity ...
- In contrast to Australia’s success with hepatitis C, our response to hepatitis B is laggingon October 15, 2019 at 12:19 am
Nicole Romero receives funding from the Australian Government Department of Health. Around one-third of Australians living with hepatitis C have been cured in the last four years. Hepatitis means ...
- Micro-elimination efforts in the UAE key to accelerate the elimination of Hepatitis C by 2030on October 13, 2019 at 2:46 am
An effective concept in the fight against HCV, micro-elimination is a strategy that pursues national elimination by targeting one population segment at a time through multi-stakeholder initiatives ...
- Donor lungs treated for Hepatitis C before transplanton October 12, 2019 at 8:11 am
Matthew Larotonda reports. Medical advances are breathing new life into patients on the waiting list for a new lung, enabling doctors to try to treat diseased lungs prior to the transplant operation.
- WisEye Morning Minute: Mapping the Opioid Epidemic - Hepatitis C Outbreakon October 10, 2019 at 6:32 am
Koepke highlighted that, "In Wisconsin, hepatitis C among people aged 15-29 increased more than 300 percent in the past decade." Although most cases are in urban areas, the rates of hepatitis C are ...
- Cocrystal Pharma Presents Data at the 26th International Symposium on Hepatitis C Virus and Related Viruseson October 8, 2019 at 11:12 am
By leveraging this technology, we were able to develop a novel class of HCV antivirals targeting the NS3 helicase that can be studied for the treatment of hepatitis C. Additionally, we were able to ...
- Hepatitis C: Should You Get Screened?on October 8, 2019 at 3:00 am
The Doctorsshare the shocking statistic that Hepatitis C kills more Americans than all other infectious diseases, even HIV. It is now being recommended that all adults, 18 to 79 years, get tested for ...
- Hepatitis C virus infection rates up for women giving birthon October 7, 2019 at 6:27 am
(HealthDay)—Among women giving birth, the rates of hepatitis C virus (HCV) infection increased more than 400 percent from 2000 to 2015, with rates much higher among those with opioid use disorder, ...
- Hepatitis C Diagnosis & Treatment Market Is Driven By Awareness Campaigns By NGOson October 7, 2019 at 3:02 am
A new report on the Hepatitis C Diagnosis & Treatment Market, published by Market Research Future (MRFR), with Major Drivers, Mega Trends, Regional Overview during the forecast period (2018-2022).
- Hepatitis C patients may be newly eligible for Medicaid coverageon October 4, 2019 at 5:24 pm
Charleston – State health officials say some low-income West Virginians with Hepatitis C may be newly eligible for coverage of their treatment. West Virginia has one of the highest rates of Hepatitis ...
via Bing News